Since 2012, Mark Goldin is a board certified physician and an attending in the Division of Hospital Medicine, Zucker School of Medicine. During that time, he has held several administrative roles. He is a member of the system Coalition of Leadership on Thrombosis and founded a local chapter at Long Island Jewish Medical Center. He also serves as team lead for the system Anticoagulation Collaborative. In medical education, Dr. Goldin has served as Director of the Zucker School of Medicine medical student clerkship in Medicine, a member of the North Shore-LIJ Residency Interview Committee, and a member of the Zucker School of Medicine Faculty Council. At the national level, Dr. Goldin has served on the Society of Hospital Medicine (SHM) Performance Measurement and Reporting Committee and the IT Quality Sub-Committee. He has presented abstracts and podium talks nationally at SHM.
Dr. Goldin’s research has focused on venous thromboembolism (VTE), perioperative care, and hospitalist-surgeon co-management. He has collaborated with the Department of Orthopaedics to study the use of aspirin for VTE prophylaxis after hip and knee arthroplasty. He is also a sub-investigator and head of recruitment at North Shore University Hosptial and Long Island Jewish Medical Center for the MARINER study, a global trial of extended post-discharge VTE prophylaxis in high-risk patients. Current work with the Division of Geriatrics and Palliative Care and the Department of Orthopaedics focuses on implementing a model of geriatric/orthopaedic co-management for patients admitted with hip fracture.
Albert Einstein College of Medicine
Field of study: Medicine